{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:57:04Z","timestamp":1779893824537,"version":"3.53.1"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T00:00:00Z","timestamp":1126051200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study assessed B\u2010cell activation, CD5 B\u2010cells and circulating immunoglobulin levels in HIV\u2010infected patients treated with combination antiretroviral therapy (CART).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Measurement of plasma immunoglobulin levels and electrophoresis of plasma proteins, and analyses of total numbers of B\u2010cells and B\u2010cells expressing CD38 and CD5 in whole blood, were undertaken in 47 consecutive HIV\u20101\u2010infected patients attending an out\u2010patient clinic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All HIV\u2010infected patients had similar percentages and numbers of B\u2010cells. Proportions of CD5 B\u2010cells in all HIV\u2010infected patients were significantly lower than those in HIV\u2010negative controls. Aviraemic HIV\u2010infected patients on CART had lower percentages of CD5, CD38 and CD5 CD38 B\u2010cell subsets and lower plasma levels of immunoglobulin G (IgG) and immunoglobulin A (IgA) than viraemic HIV\u2010infected patients (untreated or on CART). However, 33\u201337% of aviraemic HIV\u2010infected patients had IgG and IgA levels above the 95th percentile of the normal range defined in HIV\u2010seronegative donors. In aviraemic HIV\u2010infected patients, plasma IgA levels correlated only with proportions of activated (CD38) B\u2010cells. IgG levels did not correlate with the proportions of B\u2010cell subsets or any marker of HIV disease activity. Monoclonal immunoglobulins were not detected in any plasma sample.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Aviraemic HIV\u2010infected patients on CART have lower plasma levels of IgG and IgA than viraemic HIV\u2010infected patients, but levels are often above the normal range. CD5 B\u2010cell numbers are depressed, so these cells are unlikely to contribute to hypergammaglobulinaemia in HIV\u2010infected patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2005.00312.x","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T13:32:39Z","timestamp":1126099959000},"page":"307-312","source":"Crossref","is-referenced-by-count":23,"title":["The effect of combination antiretroviral therapy on CD5 B\u2010 cells, B\u2010cell activation and hypergammaglobulinaemia in HIV\u20101\u2010infected patients"],"prefix":"10.1111","volume":"6","author":[{"given":"BE","family":"Redgrave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SF","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAH","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IR","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,9,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198308253090803"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922204773004941"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/0889222041217455"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200209060-00007"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922201300343681"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200212150-00003"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200209000-00009"},{"key":"e_1_2_6_9_2","first-page":"1623","article-title":"Invasive pneumococcal disease in patients infected with HIV","volume":"38","author":"Jordano Q","year":"2004","journal-title":"still a threat in the era of highly active antiretroviral therapy"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00828.x"},{"key":"e_1_2_6_11_2","first-page":"23","article-title":"Reference values for peripheral blood B\u2010lymphocyte subpopulations","volume":"253","author":"Deneys V","year":"2001","journal-title":"a basis for multiparametric immunophenotyping of abnormal lymphocytes"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.100301.064833"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200010)30:10<2918::AID-IMMU2918>3.0.CO;2-C"},{"key":"e_1_2_6_14_2","first-page":"574","article-title":"CD5 positive B cells at the crossroads of B\u2010cell malignancy and nonorgan\u2010specific autoimmunity","volume":"48","author":"Youinou P","year":"2000","journal-title":"Pathol Biol (Paris)"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1525"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.19.10432-10436.2003"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20022020"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(92)90006-B"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(02)00155-4"},{"key":"e_1_2_6_20_2","first-page":"3721","article-title":"Possible role of interleukin\u201010 (IL\u201010) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection","volume":"92","author":"Muller F","year":"1998","journal-title":"modulation of IL-10 and Ig production after intravenous Ig infusion"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000019108"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922202320935429"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/374786"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2005.00312.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2005.00312.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T18:58:31Z","timestamp":1696877911000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2005.00312.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1111\/j.1468-1293.2005.00312.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2005.00312.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}